Ranitidin Dyna en es it fr

Ranitidin Dyna Brand names, Ranitidin Dyna Analogs

Ranitidin Dyna Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranitidin Dyna Chemical_Formula


Ranitidin Dyna RX_link


Ranitidin Dyna fda sheet

Ranitidin_Dyna FDA

Ranitidin Dyna msds (material safety sheet)

Ranitidin_Dyna MSDS

Ranitidin Dyna Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitidin Dyna Molecular Weight

314.405 g/mol

Ranitidin Dyna Melting Point

69-70 oC

Ranitidin Dyna H2O Solubility

24.7 mg/mL

Ranitidin Dyna State


Ranitidin Dyna LogP


Ranitidin Dyna Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitidin Dyna Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitidin Dyna Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitidin Dyna Absorption

Approximately 50% bioavailability orally.

Ranitidin Dyna side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitidin Dyna Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitidin Dyna Organisms Affected

Humans and other mammals